Taser International (TASR) 22.65 $TASR TASER Witnesses

New Post Public Reply Private Reply Replies (0) Message Board

Mar 4, 2015 at 6:46 PM

Taser International (TASR) 22.65 $TASR

TASER Witnesses Surge in Demand for AXON Body Cameras - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Mar 04, 1:40PM CST
TASER (TASR) declared that it has received large orders for its AXON body-worn cameras and the EVIDENCE.com solution from several law enforcement agencies.
UEPS: 14.62 (+1.02), DMRC: 22.75 (-0.26), NSSC: 5.55 (+0.14), TASR: 22.65 (+0.72)

Smith & Wesson (SWHC) Shares Rally on Q3 Earnings Beat - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Mar 04, 8:00AM CST
Smith & Wesson Holding Corp. (SWHC) reported non-GAAP third-quarter fiscal 2015 (ending Jan 31, 2015) earnings from continuing operations of 20 cents per share, beating the Zacks Consensus Estimate of 11 cents by 81.8%.
POOL: 68.54 (-0.82), TASR: 22.65 (+0.72), RGR: 54.64 (+1.94), SWHC: 14.34 (+1.29)

Tucson Becomes 16th Major City to Deploy TASER's AXON Body Cameras; Selects New EVIDENCE.com Unlimited Plan
PR Newswire - Tue Mar 03, 6:30AM CST
TASER International (NASDAQ: TASR) today announced large orders of its AXON body-worn video cameras and EVIDENCE.com solution, a back-end digital evidence management system. These orders were received in the first quarter of 2015 and are expected to ship in the first quarter of 2015. The company further announced last week that the number of agencies on the EVIDENCE.com platform recently surpassed 5,000, or more than a quarter of law enforcement agencies in the United States.
TASR: 22.65 (+0.72)

Nasdaq stocks posting largest percentage decreases
AP - Fri Feb 27, 5:02PM CST
NEW YORK (AP) — A look at the 10 biggest percentage decliners on Nasdaq at the close of trading:
RESN: 11.44 (+0.49), PEGA: 20.33 (-0.32), IQNT: 15.59 (+0.43), PFMT: 4.15 (-0.24), HAWKB: 35.22 (+1.07), STAA: 7.31 (-0.45), LKQ: 24.03 (-0.89), VTAE: 11.09 (-0.06), BDBD: 10.63 (+0.25), HAWK: 35.56 (+1.05), RMTI: 10.40 (+0.12), PLKI: 60.86 (-0.50), ANIK: 39.46 (unch), TASR: 22.65 (+0.72), SNMX: 4.29 (-0.27)

Taser International (TASR) Showing Signs Of A Dead Cat Bounce Today
at The Street - Fri Feb 27, 8:45AM CST
Trade-Ideas LLC identified Taser International (TASR) as a "dead cat bounce" (down big yesterday but up big today) candidate
TASR: 22.65 (+0.72)

Craig-Hallum: Taser sell-off 'massive overreaction'
Seeking Alpha - at Seeking Alpha - Fri Feb 27, 6:55AM CST

TASR: 22.65 (+0.72)

Taser loses zap on '15 outlook
at Investor's Business Daily - Thu Feb 26, 5:33PM CST
The stun gun and wearable camera maker's shares plunged 16% after it said investments needed to boost int'l revenue and in the Axon body-camera segment will result in higher costs in '15. Taser (TASR) earned 9 cents in Q4, down a penny from a year...
TASR: 22.65 (+0.72)

TASER International's (TASR) CEO Rick Smith on Q4 2014 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Thu Feb 26, 4:53PM CST

TASR: 22.65 (+0.72)

Why TASER International, Inc. Dropped 16% Today
Travis Hoium, The Motley Fool - Motley Fool - Thu Feb 26, 12:24PM CST
Although we don't believe in timing the market or panicking over market movements, we do like to keep an eye on big changes -- just in case they're material to our investing thesis. What: Shares of law enforcement equipment maker TASER...
TASR: 22.65 (+0.72)

Midday Gainers / Losers
Seeking Alpha - at Seeking Alpha - Thu Feb 26, 11:57AM CST

FRO: 2.60 (+0.02), HAWKB: 35.22 (+1.07), ARQL: 1.91 (+0.04), MNDO: 3.99 (+0.09), BIOC: 3.39 (+0.01), MRGE: 4.61 (+0.12), CYBX: 71.19 (+0.83), CWEI: 46.53 (+0.41), ELX: 7.98 (unch), ATOS: 2.03 (+0.07), IQNT: 15.59 (+0.43), FLML: 15.84 (-0.06), ONE: 2.80 (-0.12), CLRX: 1.27 (-0.05), PGTI: 11.28 (+0.33), ESSX: 0.71 (-0.05), HMNY: 3.45 (-0.17), TASR: 22.65 (+0.72), MSLI: 2.09 (-0.04), UIL: 50.62 (+0.22)

Taser Sees Costs Growing Amid Camera, Overseas Push
at Investor's Business Daily - Thu Feb 26, 11:57AM CST
Taser International (TASR) expects investments needed to boost revenues internationally and in the Axon body-camera segment will result in higher costs this year after expenses weighed on fourth-quarter earnings. The maker of stun guns and wearable...
TASR: 22.65 (+0.72), RGR: 54.64 (+1.94), DGLY: 13.18 (-1.04)

The Dow Treads Water as Ballard Power, TASER Plunge
Dan Caplinger, The Motley Fool - Motley Fool - Thu Feb 26, 11:47AM CST
Ballard Power took a big hit following its earnings report. Photo: Ballard Power Systems. The stock market has calmed down considerably in recent days, stepping off the roller-coaster it had ridden through much of January and February as investors...
BLDP: 2.27 (-0.06), TASR: 22.65 (+0.72)

TASER International Misses on Q4 Earnings, Bookings Surge - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Feb 26, 10:11AM CST
TASER International's (TASR) fourth-quarter earnings fell short of the Zacks Consensus Estimate while revenues surpassed the mark.
UEPS: 14.62 (+1.02), DMRC: 22.75 (-0.26), NSSC: 5.55 (+0.14), TASR: 22.65 (+0.72)

TASER (TASR) Stock Is Down Today on Earnings Miss
at The Street - Thu Feb 26, 10:07AM CST
TASER (TASR) is falling Thursday after missing analysts' estimates for earnings in the fourth quarter.
TASR: 22.65 (+0.72)

TASER International (TASR) Q4 2014 Results - Earnings Call Webcast
SA Transcripts - at Seeking Alpha - Thu Feb 26, 8:55AM CST

TASR: 22.65 (+0.72)

Stock Futures Narrowly Higher; Salesforce, Avago, Akorn Rocket
at Investor's Business Daily - Thu Feb 26, 8:11AM CST
Stock futures flattened their early gains Thursday after a spate of mixed economic news. Dow futures traded 1.4 points above fair market value. Nasdaq 100 futures pared gains to 3 points. S&P 500 futures maintained a fractional gain. The Stock Market...
ELX: 7.98 (unch), AKRX: 51.19 (+1.86), TASR: 22.65 (+0.72), AVGO: 129.40 (+1.18), CRM: 64.88 (-2.07)

TASER International (TASR) Lags Q4 Earnings by a Penny - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Thu Feb 26, 7:49AM CST
TASER International (TASR) Lags Q4 Earnings by a Penny
TASR: 22.65 (+0.72)

Taser misses 4Q profit forecasts
AP - Thu Feb 26, 7:41AM CST
SCOTTSDALE, Ariz. (AP) — Taser International Inc. (TASR) on Thursday reported fourth-quarter net income of $5.1 million.
TASR: 22.65 (+0.72)

Taser drops after missing profit forecasts
Seeking Alpha - at Seeking Alpha - Thu Feb 26, 7:02AM CST

TASR: 22.65 (+0.72)

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

UWM Faces Class Action Deadline: Key Insights for Investors

The High Stakes Reality for UWM Investors If there's one thing that's certain in this jittery world of investing, it's that losses have a way of waking you up. Right now, anyone tied up with UWM Holdings Corporation (NYSE: UWMC) shares needs to keep their wits about them; we're barreling toward an October 13, 2026 deadline for a class action lawsuit. The clock's ticking...

GORGIE Unleashes Berry Burst: Target's New Drink Star

GORGIE Targets Taste Buds with Berry Burst Ever feel like you're missing out on that energy drink everyone seems to be raving about? Well, GORGIE's out there making some noise again, and this time it's got a new punchy player in the game: Berry Burst. It's not just another drink; it's shaking things up in the energy aisle with its exclusive launch at Target. Modern style...

Ris-Rez May Set New Standard in Relapsed SCLC

The Game-Changing Results Innovation in pharmaceuticals sometimes feels like a waiting game, but when a fresh breakthrough like this rolls in, it lights up the whole landscape. Risvutatug rezetecan, or Ris-Rez for short, has shown promising potential in the fight against relapsed small-cell lung cancer (SCLC) that has progressed after platinum-based therapy. Survival...

Trial Disappointment: No Significant Gains in NSCLC

Dissecting the Nuances of the EVOKE-03/KEYNOTE-D46 Trial Every once in a while, we come across a trial that rattles cages in the research community. Today, it's the EVOKE-03/KEYNOTE-D46 trial, a collision of hope and hard-knock reality. This Phase 3 trial, which sought to explore the potential combo of sacituzumab govitecan (SG) and pembrolizumab on metastatic non-small...

PwC US and India Unite for Global Consultancy Powerhouse

Rearranging the Consultancy Chessboard Piling onto the game of consultancy realignments, PwC just made a move reminiscent of playing strategy poker. They're tossing together PwC US and PwC India's advisory capabilities for a new joint venture. It’s like pushing two puzzle pieces to make a single colorful picture that stretches from the U.S. all the way to the...

PANDAG G1 Debuts: Revolutionizing Lawn Care Efficiency

The Future of Landscaping Unveiled Get this—PANDAG is set to shake things up at GaLaBau 2026 with their futuristic G1 autonomous mower. This isn't just another piece of lawn equipment; it's practically a tech marvel on wheels, weaving together LiDAR, AI Vision, RTK, and 4G tech to make it the ultimate multitasker for the landscaping industry. We're talking obstacle...

MRI Surveillance Gains Ground in Lung Cancer Care

Shifting the Standard: MRI's Rise in SCLC Treatment Here's a twist that baffles the traditionalists—ditch the prophylactic cranial irradiation (PCI) and catch clearer days with MRI surveillance for small-cell lung cancer (SCLC). The latest international phase III MAVERICK trial might just redraw the lines on what's considered standard care in this relentless disease....

First-Time Homeowners: Unseen Pitfalls of Insurance

Understanding Homeowners Insurance: Beyond the Basics Most folks diving into homeownership for the first time get caught up in the whirlwind of price tags, loans, and knick-knacks for their new place. Meanwhile, the nitty-gritty of homeowners insurance often gets tossed to the side. But take it from a weary watchdog of financial storms—it’s those details in the policy...

Surfing Dogs Ride Waves, Support Orphan Pets

Waves, Paws, and Passion Who would've thought that dogs catching waves could also catch hearts and wallets? Well, that's exactly what's happening today at Del Mar Dog Beach with the 21st Annual Surf Dog Surf-A-Thon revving up the excitement. It's a sun-soaked day in Rancho Santa Fe, California, right in the thick of things at the longest-running dog surf competition. For...

Tam-Peli Steps Up in SCLC Battle: Trial Insights

Noteworthy Developments in Small-Cell Lung Cancer Treatment Let's dive into a story straight from the world of small-cell lung cancer (SCLC) that doesn't take any prisoners. The antidote making waves is tambotatug pelitecan, or Tam-Peli for short, showcasing its might in the unrelenting fight against relapsed SCLC. The phase III TAISHAN-302 trial puts Tam-Peli...